These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 29644494)

  • 21. Evaluation of the effects of sequence length and microsatellite instability on single-guide RNA activity and specificity.
    Zhao C; Wang Y; Nie X; Han X; Liu H; Li G; Yang G; Ruan J; Ma Y; Li X; Cheng H; Zhao S; Fang Y; Xie S
    Int J Biol Sci; 2019; 15(12):2641-2653. PubMed ID: 31754336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditional editing of the
    Wang BZ; Zhang C; Zhang JL; Sun J
    Yi Chuan; 2023 Jul; 45(7):593-601. PubMed ID: 37503583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pinpoint modification strategy for stabilization of single guide RNA.
    Takeuchi S; Yamamoto M; Matsumoto S; Kenjo E; Karashima M; Ikeda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123149. PubMed ID: 35139474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Bicistronic Vector for the Expression of a CRISPR/Cas9-mCherry System in Fish Cell Lines.
    Escobar-Aguirre S; Arancibia D; Escorza A; Bravo C; Andrés ME; Zamorano P; Martínez V
    Cells; 2019 Jan; 8(1):. PubMed ID: 30669572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas9-Mediated Genome Editing in Paenibacillus polymyxa.
    Ravagnan G; Meliawati M; Schmid J
    Methods Mol Biol; 2024; 2760():267-280. PubMed ID: 38468094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OffScan: a universal and fast CRISPR off-target sites detection tool.
    Cui Y; Liao X; Peng S; Tang T; Huang C; Yang C
    BMC Genomics; 2020 Mar; 21(Suppl 1):872. PubMed ID: 32138651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas bioinformatics.
    Alkhnbashi OS; Meier T; Mitrofanov A; Backofen R; Voß B
    Methods; 2020 Feb; 172():3-11. PubMed ID: 31326596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. iCRISEE: an integrative analysis of CRISPR screen by reducing false positive hits.
    Zhang T; Li Y; Yang Y; Weng L; Wu Z; Zhu J; Qin J; Liu Q; Wang P
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34905767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering.
    Ui-Tei K; Maruyama S; Nakano Y
    Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview.
    Araldi RP; Khalil C; Grignet PH; Teixeira MR; de Melo TC; Módolo DG; Fernandes LGV; Ruiz J; de Souza EB
    Gene; 2020 Jun; 745():144636. PubMed ID: 32244056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs.
    Wang X; Zhou J; Cao C; Huang J; Hai T; Wang Y; Zheng Q; Zhang H; Qin G; Miao X; Wang H; Cao S; Zhou Q; Zhao J
    Sci Rep; 2015 Aug; 5():13348. PubMed ID: 26293209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing Rice Mutants Using CRISPR/Cas9-Based Genome Editing Technology.
    Xu K; Li Y
    Methods Mol Biol; 2022; 2400():11-19. PubMed ID: 34905186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Split-and-Click" sgRNA.
    Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
    Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An introduction and use of the CRISPR-Cas systems.
    Singh V
    Prog Mol Biol Transl Sci; 2021; 179():1-10. PubMed ID: 33785173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [sgRNA design for the CRISPR/Cas9 system and evaluation of its off-target effects].
    Xie SS; Zhang Y; Zhang LS; Li GL; Zhao CZ; Ni P; Zhao SH
    Yi Chuan; 2015 Nov; 37(11):1125-36. PubMed ID: 26582526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.